loadpatents
name:-0.0092830657958984
name:-0.018494844436646
name:-0.0033168792724609
MARCHI; Egidio Patent Filings

MARCHI; Egidio

Patent Applications and Registrations

Patent applications and USPTO patent grants for MARCHI; Egidio.The latest application filed is for "pyrido-imidazo rifamycins".

Company Profile
2.16.7
  • MARCHI; Egidio - Casalecchio di Reno IT
  • Marchi; Egidio - Casalecchio di Reno Bologna
  • Marchi; Egidio - Bologna IT
  • Marchi; Egidio - Casalecchio de Reno IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrido-imidazo Rifamycins
App 20210363143 - MARCHI; Egidio ;   et al.
2021-11-25
Pyrido-imidazo rifamycins
Grant 11,028,086 - Marchi , et al. June 8, 2
2021-06-08
Pyrido-imidazo Rifamycins
App 20200157104 - MARCHI; Egidio ;   et al.
2020-05-21
Modus of administration of iron, and new formulations adapted for the said goal
Grant 10,543,216 - Santi , et al. Ja
2020-01-28
New Modus Of Administration Of Iron, And New Formulations Adapated For The Said Goal
App 20160151384 - SANTI; Patrizia ;   et al.
2016-06-02
Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars
Grant 8,993,748 - Sacchi , et al. March 31, 2
2015-03-31
Process For The Preparation Of Trivalent Iron Complexes With Mono-, Di- And Polysaccharide Sugards
App 20140296508 - Sacchi; Stefania ;   et al.
2014-10-02
Low molecular weight complexes between iron and maltobionic acid, use thereof for intramuscular or subcutaneous administration in the treatment of anemic states, and new pharmaceutical compositions adapted for these uses
Grant 8,828,967 - Autuori , et al. September 9, 2
2014-09-09
Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars
Grant 8,759,320 - Sacchi , et al. June 24, 2
2014-06-24
New Low Molecular Weight Complexes Between Iron And Maltobionic Acid, Use Thereof For Intramuscular Or Subcutaneous Administration In The Treatment Of Anemic States, And New Pharmaceutical Compositions Adapted For These Uses
App 20130079298 - Autuori; Michele ;   et al.
2013-03-28
Process for the Preparation of Trivalent Iron Complexes with Mono-, Di- and Polysaccharide Sugars
App 20080207558 - Sacchi; Stefania ;   et al.
2008-08-28
Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it
Grant 5,496,807 - Marchi , et al. March 5, 1
1996-03-05
Programmed release tablets containing naproxen
Grant 5,480,650 - Marchi , et al. January 2, 1
1996-01-02
Pharmaceutical compositions containing orally absorbable glycosamimoglycans
Grant 5,252,339 - Cristofori , et al. October 12, 1
1993-10-12
Injectable formulations containing the sodium salt of naproxen
Grant 5,096,926 - Fiorini , et al. March 17, 1
1992-03-17
Galenic formulations with programmed release
Grant 5,043,167 - Rotini , et al. August 27, 1
1991-08-27
Galenic formulations with programmed release containing naproxen
Grant 4,888,178 - Rotini , et al. December 19, 1
1989-12-19
Imidazo-rifamycin derivatives with antibacterial utility
Grant 4,341,785 - Marchi , et al. July 27, 1
1982-07-27
Rifamycin derivatives and process for their preparation
Grant 4,200,574 - Marchi , et al. April 29, 1
1980-04-29
Process for the preparation of 3 iodo- and 3 bromorifamycin s
Grant 4,179,438 - Marchi , et al. December 18, 1
1979-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed